Patent details

Basic Information

Publication number:

EP2067772

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP091533752

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Dibenzo (b,f) azepine intermediates

French Title of Invention:

Dérivés de dibenzoÖb,fÜazepine et leur préparation

German Title of Invention:

DibenzoÖb,fÜazepin-Derivate und ihre Herstellung

SPC Number:

Dates

Filing date:

07/02/2001

Grant date:

13/04/2011

EP Publication Date:

13/04/2011

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

10/06/2009

EP B1 Publication Date:

13/04/2011

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

07/02/2019

Expiration date:

07/02/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

07/02/2001

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Name:

Novartis Pharma GmbH

Address:

Brunner Strasse 59, 1230 Wien, Austria (AT)

Inventor

1

Name:

Kaufmann Daniel

Address:

Switzerland (CH)

2

Name:

Beutler Ulrich

Address:

Switzerland (CH)

3

Name:

Lohse Olivier

Address:

France (FR)

4

Name:

Fünfschilling Peter

Address:

Switzerland (CH)

5

Name:

Zaugg Werner

Address:

Switzerland (CH)

Priority

Priority Number:

0002740

Priority Date:

07/02/2000

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

C07D 223/22;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

24/01/2018

Last Annual Fee Paid Number:

18

Last Annual Fee Paid Amount:

262 Euro

Payer:

MARKS & CLERK LLP

Filing date	Document type	Number of pages